HR 1 - Big Beautiful Bill Act
Literal federal measure citations: HR 1
2025 · 2nd Quarter (Apr 1 - June 30)
RARE DISEASE COMPANY COALITION
Filed by RARE DISEASE COMPANY COALITION.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 18, 2025
- Income
- Not reported
- Expenses
- $70,000.00
- Registrant
- RARE DISEASE COMPANY COALITION
- Filing UUID
- 661ca242-e2bc-4a4a-b60c-a9468ed9c696
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
HR 1262 - Give Kids a Chance Act of 2025 S 932 - Give Kids a Chance Act of 2025 HR 946 - ORPHAN Cures Act S 1862 - ORPHAN Cures Act HR 1414 - Camerons Law FDA Regulatory Priorities
Literal federal measure citations: HR 1262, S 932, HR 946, S 1862, HR 1414
Executive Order 14297 - Impact of EO on Rare Disease Innovation Rare Disease Policy
Sec. 232 Pharmaceutical Tariffs
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.